Companies: 10,795·Total market cap: $144.5T
HEXO Corp.

HEXO Corp.

HEXONASDAQHealthcare
$0.71
+$0.02(+2.45%)
Market Cap$31237444
P/E Ratio
52W High$3.836
52W Low$0.66
Overview

HEXO Corp. (HEXO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hexo · pe ratio · data through Jul 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for HEXO Corp. (HEXO) measures how much investors pay for each dollar of the company's trailing earnings. HEXO's current PE ratio of N/A is calculated by dividing its stock price of $0.71 by its TTM earnings per share of -$38.68.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-07-31

Forward P/E
N/A
EPS (TTM)
-$38.68
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HEXO Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2014 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
HEXO Corp.
HEXO Corp.You
HEXO
$31MN/A-$38.68
Allakos Inc.
Allakos Inc.
ALLK
$30MN/A-$1.30
Angion Biomedica Corp.
Angion Biomedica Corp.
ANGN
$30MN/A-$2.58
Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc.
CYTH
$24MN/A-$1.23
IsoPlexis Corporation
IsoPlexis Corporation
ISO
$30MN/A-$2.94
LianBio
LianBio
LIANY
$12M2.11x$0.05
Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals, Inc.
MRNS
$30MN/A-$2.63

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-07-31Latest
FY2022
$-38.68
2021-07-31
FY2021
$-12.62
2020-07-31
FY2020
$-63.43
2019-07-31
FY2019
$-21.47
2018-07-31
FY2018
$-9.75
2017-07-31
FY2017
$-11.88
2015-09-30
FY2015
$0.00
2015-06-30
FY2015
$-0.92
2014-06-30
FY2014
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for HEXO Corp. (HEXO) measures how much investors pay for each dollar of the company's trailing earnings. HEXO's current PE ratio of N/A is calculated by dividing its stock price of $0.71 by its TTM earnings per share of -$38.68.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.71 ÷ -$38.68 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HEXO pe ratio · 6 questions

HEXO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.71 and TTM EPS of -$38.68. Data sourced from Financial Modeling Prep via HEXO's SEC 10-K and 10-Q filings.

HEXO PE ratioWhat is HEXO PE ratioCurrent PE ratio of HEXOHEXO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HEXO Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09